{"nct_id":"NCT00801060","title":"Evaluation of Safety and Efficacy of Fludarabine, Cyclophosphamide, and Rituximab (FCR) +/- Lumiliximab in Subjects With Previously Untreated Chronic Lymphocytic Leukemia (CLL)","status":"TERMINATED","status_verified_date":"2011-04","start_date":"2008-02","start_date_type":null,"primary_completion_date":"2010-06","primary_completion_date_type":"ACTUAL","completion_date":"2010-09","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["BIIB"]}